Author: Weimert Nicole A.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.67, Iss.11, 2007-01, pp. : 1603-1627
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Renal failure with zoledronic acid: patients already high-risk
Inpharma, Vol. 1, Iss. 1411, 2003-01 ,pp. :
Epoprostenol preserves renal function after coronary bypass surgery in high-risk patients
Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. :
Abciximab for high-risk patients: effective at a cost
Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. :
StatusOne for high-risk patients yields millions
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :